Confirming media reports, Baxter International announced it has agreed to sell its BioPharma Solutions (BPS) business to a private equity consortium of Warburg Pincus and...
A private equity consortium of Warburg Pincus and Advent International is said to be in advanced talks to acquire medical device maker Baxter International’s biopharma...
Under the name Envalior, German specialty chemicals producer Lanxess and private equity investor Advent International launched their new 40:60 joint venture for high...
2021 was historic for chemical M&As, it was a record-breaking year in terms of total value of deals. Therefore, it was expected that 2022 would only build upon this...
With merger clearance granted by India this week, nothing now stands in the way of plans by German chemical producer Lanxess and private equity investor Advent...
The planned 60:40 specialty materials joint venture of German chemical producer and private equity group Advent International, announced at the end of May, is gradually...
12.07.2018
- French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9...
18.04.2018
- French drugmaker Sanofi has confirmed market speculation that it is talking to Advent International about a sale of its European generics division, which trades as Zentiva. The...
